ACARIX AB
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more
Market Cap & Net Worth: ACARIX AB (7AC)
ACARIX AB (F:7AC) has a market capitalization of $23.64 Million (€23.03 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25186 globally and #2763 in its home market, demonstrating a 17.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ACARIX AB's stock price €0.02 by its total outstanding shares 1123320142 (1.12 Billion).
ACARIX AB Market Cap History: 2016 to 2026
ACARIX AB's market capitalization history from 2016 to 2026. Data shows change from $1.80 Billion to $23.64 Million (-37.50% CAGR).
ACARIX AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ACARIX AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7AC by Market Capitalization
Companies near ACARIX AB in the global market cap rankings as of March 19, 2026.
Key companies related to ACARIX AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
ACARIX AB Historical Marketcap From 2016 to 2026
Between 2016 and today, ACARIX AB's market cap moved from $1.80 Billion to $ 23.64 Million, with a yearly change of -37.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €23.64 Million | +19.19% |
| 2025 | €19.83 Million | +17.01% |
| 2024 | €16.95 Million | -3.29% |
| 2023 | €17.53 Million | -15.08% |
| 2022 | €20.64 Million | -76.29% |
| 2021 | €87.06 Million | -28.44% |
| 2020 | €121.65 Million | -10.21% |
| 2019 | €135.48 Million | -61.39% |
| 2018 | €350.88 Million | -65.90% |
| 2017 | €1.03 Billion | -42.82% |
| 2016 | €1.80 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ACARIX AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.64 Million USD |
| MoneyControl | $23.64 Million USD |
| MarketWatch | $23.64 Million USD |
| marketcap.company | $23.64 Million USD |
| Reuters | $23.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.